Hepcidin Is a Reliable Marker of Iron Deficiency Anemia in Newly Diagnosed Patients with Inflammatory Bowel Disease

Dis Markers. 2020 Nov 28:2020:8523205. doi: 10.1155/2020/8523205. eCollection 2020.

Abstract

Results: There was a high statistically significant difference between IBD patients and controls in levels of hepcidin (P < 0.01). Namely, serum hepcidin levels were significantly higher in the control group. There was no statistically significant correlation of serum hepcidin with CRP, Mayo score, or CDAI, respectively (P > 0.05). However, we have found a statistically significant negative correlation of sTfR and TIBC with hepcidin (P < 0.01).

Conclusion: Results of our study suggest that hepcidin is a reliable marker of IDA in patients with IBD, and it could be used in routine clinical practice when determining adequate therapy in these patients.

MeSH terms

  • Adult
  • Anemia, Iron-Deficiency / blood*
  • Anemia, Iron-Deficiency / etiology*
  • Biomarkers / blood
  • Blood Cell Count
  • Case-Control Studies
  • Female
  • Ferritins / blood
  • Hepcidins / blood*
  • Humans
  • Inflammatory Bowel Diseases / complications*
  • Male
  • Middle Aged

Substances

  • Biomarkers
  • HAMP protein, human
  • Hepcidins
  • Ferritins